Lexaria Bioscience Patents – Key Insights and Stats

Lexaria Bioscience has a total of 108 patents globally, out of which 10 have been granted. Of these 108 patents, more than 75% patents are active. The USA is where Lexaria Bioscience has filed the maximum number of patents, followed by Australia, . Parallelly, the USA seems to be the main focused R&D centre of Lexaria Bioscience.

Lexaria Bioscience was founded in the year 2004. The firm is a biotechnology company that carries out the manufacturing and selling of existing and new ingestible products. As of November 2022, Lexaria Bioscience has a market cap of $14.16 Million.

Do read about some of the most popular patents of Lexaria Bioscience which have been covered by us in this article and also you can find Lexaria Bioscience patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Lexaria Bioscience patent portfolio.

How many patents does the CEO of Lexaria Bioscience have?

The CEO, Chris Bunka, has 0 patents.

How many patents does Lexaria Bioscience have?

Lexaria Bioscience has a total of 108 patents globally. These patents belong to 15 unique patent families. Out of 108 patents, 81 patents are active.

How Many Patents did Lexaria Bioscience File Every Year?

Lexaria Bioscience Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantLexaria Bioscience Applications FiledLexaria Bioscience Patents Granted
202221
2021105
202018
201929
2018182
201761
2016161
20159
2014
2013
2012
2011

How many Lexaria Bioscience patents are Alive/Dead?

Lexaria Bioscience Patent Portfolio

How Many Patents did Lexaria Bioscience File in Different Countries?

Lexaria Bioscience Worldwide Patent Filing

Countries in which Lexaria Bioscience Filed Patents

CountryPatents
United States Of America26
Australia25
Canada12
Europe12
Japan7
Mexico4
China3
India3
Spain1
Hong Kong (S.A.R.)1

Where are Research Centres of Lexaria Bioscience Patents Located?

All the R&D centres of Lexaria Bioscience patents are filed in the USA.

10 Best Lexaria Bioscience Patents

US9474725B1 is the most popular patent in the Lexaria Bioscience portfolio. It has received 20 citations so far from companies like Schweitzer-Mauduit International, Quicksilver Scientific, and Altopa.

Below is the list of 10 most cited patents of Lexaria Bioscience:

Publication NumberCitation Count
US9474725B120
US9974739B212
WO2015191728A112
US9972680B211
WO2017100063A210
US20160367479A18
US20180117161A18
WO2017100062A17
WO2019245639A17
WO2019178360A16

What are Lexaria Bioscience key innovation segments?

What Technologies are Covered by Lexaria Bioscience?

The chart below distributes patents filed by Lexaria Bioscience in different countries on the basis of the technology protected in patents. It also represents the markets where Lexaria Bioscience thinks it’s important to protect particular technology inventions.

R&D Focus: How has Lexaria Bioscience search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Lexaria Bioscience?

Table of Content

Insights you may find interesting

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.